Browsing Tag
INFY
4 posts
What FY27 guidance means for Infosys (NSE: INFY) investors now
INFY has profit and AI ambition, but guidance is cautious. FY27 will test whether Infosys can turn stability into a recovery trade.
Infosys agrees to acquire Optimum Healthcare IT for $465m in its second-largest deal, targeting AI-led transformation of US provider market
Infosys to acquire Optimum Healthcare IT for $465M to lead AI-driven US health system transformation. Read the full strategic and market analysis.
Infosys Q2 FY26 earnings analysis: Can consistent execution and AI investments offset top-line caution?
Infosys delivered a stable Q2 FY26 with ₹7,364 Cr in net profit, ₹18,000 Cr buyback, and $3.1B in large deals. Can its AI-led strategy sustain investor trust?
Infosys Q2 FY26 results: Why the stock dipped 0.24% despite Rs 18,000cr buyback
Infosys shares slipped 0.24% despite a ₹18,000 crore buyback, strong Q2 FY26 performance, and rising cash flow. Find out what this means for investors.